Lasa Supergenerics Ltd (LASA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1002834,
    "name": "Lasa Supergeneri",
    "stock_name": "Lasa Supergeneri",
    "full_name": "Lasa Supergenerics Ltd",
    "name_url": "stocks-analysis/lasa-supergeneri",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5.96",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "5.96",
    "mcapval": "30.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540702,
    "symbol": "LASA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE670X01014",
    "curr_date": "Sep 25, 03:30 PM",
    "curr_time": "10:47 AM",
    "last_traded_at": "Sep 25, 03:30 PM IST",
    "bse_nse_vol": "22.07 k",
    "exc_status": "Active",
    "traded_date": "Sep 25, 2026",
    "traded_date_str": "2026 09 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lasa-supergeneri-1002834-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-4162550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LasaSupergeneri_mojoScore_4162550.png",
        "date": "2026-08-20 10:10:22",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 August 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Are Lasa Supergenerics Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-lasa-supergenerics-ltd-latest-results-good-or-bad-4154758",
        "imagepath": "",
        "date": "2026-08-14 19:53:31",
        "description": "Lasa Supergenerics Ltd's latest financial results for the fourth quarter of FY26 reveal a significant operational crisis. The company reported negative net sales of ₹0.13 crores, indicating a complete collapse in revenue generation, with a staggering year-on-year decline of 100.33% from ₹39.14 crores in March 2025. This unprecedented situation suggests that the company may have faced substantial sales reversals or accounting adjustments that overwhelmed any minimal revenue generated during the quarter.\n\nThe net loss for the same period widened to ₹4.16 crores, reflecting a sequential deterioration of 63.14% from the previous quarter's loss of ₹2.55 crores. The operating profit (PBDIT) also deteriorated to a loss of ₹2.11 crores, yielding an operating margin that is rendered meaningless due to the negative revenue base. The company's return on equity (ROE) stands at a low 0.32%, indicating severely weak capi..."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-4139663",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LasaSupergeneri_mojoScore_4139663.png",
        "date": "2026-08-06 10:10:42",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "When is the next results date for Lasa Supergenerics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-lasa-supergenerics-ltd-4138797",
        "imagepath": "",
        "date": "2026-08-05 23:20:09",
        "description": "Lasa Supergenerics Ltd is scheduled to declare its results on 14 August 2026...."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-4117645",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LasaSupergeneri_mojoScore_4117645.png",
        "date": "2026-07-23 10:10:26",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis below reflects the stock’s current position as of 23 July 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective."
      },
      {
        "title": "Lasa Supergenerics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergenerics-ltd-is-rated-strong-sell-4084745",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/LasaSupergeneri_mojoScore_4084745.png",
        "date": "2026-07-02 10:10:53",
        "description": "Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 265,
    "sid": "1002834",
    "stock_news_url": "https://www.marketsmojo.com/news/lasa-supergenerics-1002834"
  },
  "announcements": [
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "19-Sep-2026",
      "details": "Annual report for FY 2025-26",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of The Baord Meeting",
      "datetime": "09-Sep-2026",
      "details": "Outcome of the board meeting",
      "source": "BSE"
    },
    {
      "caption": "Notice Of The Annual General Meeting",
      "datetime": "09-Sep-2026",
      "details": "Notice of annual general meeting",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lasa Supergenerics Ltd has declared <strong>2%</strong> dividend, ex-date: 16 Sep 22",
          "dt": "2022-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lasa Supergenerics Ltd is Rated Strong Sell

2026-08-20 10:10:22

Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Are Lasa Supergenerics Ltd latest results good or bad?

2026-08-14 19:53:31

Lasa Supergenerics Ltd's latest financial results for the fourth quarter of FY26 reveal a significant operational crisis. The company reported negative net sales of ₹0.13 crores, indicating a complete collapse in revenue generation, with a staggering year-on-year decline of 100.33% from ₹39.14 crores in March 2025. This unprecedented situation suggests that the company may have faced substantial sales reversals or accounting adjustments that overwhelmed any minimal revenue generated during the quarter. The net loss for the same period widened to ₹4.16 crores, reflecting a sequential deterioration of 63.14% from the previous quarter's loss of ₹2.55 crores. The operating profit (PBDIT) also deteriorated to a loss of ₹2.11 crores, yielding an operating margin that is rendered meaningless due to the negative revenue base. The company's return on equity (ROE) stands at a low 0.32%, indicating severely weak capi...

Read full news article

Lasa Supergenerics Ltd is Rated Strong Sell

2026-08-06 10:10:42

Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.

Read full news article

When is the next results date for Lasa Supergenerics Ltd?

2026-08-05 23:20:09

Lasa Supergenerics Ltd is scheduled to declare its results on 14 August 2026....

Read full news article

Lasa Supergenerics Ltd is Rated Strong Sell

2026-07-23 10:10:26

Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis below reflects the stock’s current position as of 23 July 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective.

Read full news article

Lasa Supergenerics Ltd is Rated Strong Sell

2026-07-02 10:10:53

Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News